Effects of a sedative antihistamine, D-chlorpheniramine, on regional cerebral perfusion and performance during simulated car driving

Manabu Tashiro, Yumiko Sakurada, Hideki Mochizuki, Etsuo Horikawa, Masahiro Maruyama, Nobuyuki Okamura, Shoichi Watanuki, Hiroyuki Arai, Masatoshi Itoh, Kazuhiko Yanai

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objectives: The sedative side effects of antihistamines have been recognized to be potentially dangerous in car driving, but the mechanism underlying these effects has not yet been elucidated to date. The aim of the present study is to examine regional cerebral blood flow (rCBF) responses during a simulated car-driving task following oral administration of D-chlorpheniramine using positron emission tomography (PET) and [15O]H2O, based on a single-blind cross-over study-design. Methods: Right-handed, healthy male volunteers (n = 14) drove a car in a simulated environment following oral administration of D-chlorpheniramine repetab 6 mg or placebo. Their rCBF was measured using PET with [15O]H2O in the following three conditions: (1) resting, (2) active driving, and (3) passive driving. All 'in-car' views during the simulated driving were videotaped and used for rating driving performance. Results: Performance evaluation revealed that the number of lane deviations significantly increased in the D-chlorpheniramine condition compared with the placebo condition (p <0.01). Subjective sleepiness was not significantly different between the two drug conditions. The regions of diminished brain responses following D-chlorpheniramine treatment were detected in the parietal, temporal and visual cortices, and in the cerebellum. The regions of augmented rCBF responses were found in the orbitofrontal cortex and cerebellar vermis. Conclusion: These results suggest that D-chlorpheniramine tends to suppress visuo-spatial cognition and visuo-motor coordinating functions rather than attention and motor functions during car driving.

Original languageEnglish (US)
Pages (from-to)139-150
Number of pages12
JournalHuman Psychopharmacology
Volume23
Issue number2
DOIs
StatePublished - Mar 1 2008
Externally publishedYes

Fingerprint

Chlorpheniramine
Histamine Antagonists
Hypnotics and Sedatives
Cerebrovascular Circulation
Perfusion
Regional Blood Flow
Positron-Emission Tomography
Cross-Over Studies
Oral Administration
Placebos
Parietal Lobe
Visual Cortex
Temporal Lobe
Prefrontal Cortex
Cerebellum
Cognition
Healthy Volunteers
Brain
Pharmaceutical Preparations

Keywords

  • Antihistamine
  • Car driving
  • Cerebral blood flow
  • Impaired performance
  • PET

ASJC Scopus subject areas

  • Pharmacology
  • Psychology(all)
  • Neuroscience(all)
  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Neurology
  • Clinical Neurology

Cite this

Effects of a sedative antihistamine, D-chlorpheniramine, on regional cerebral perfusion and performance during simulated car driving. / Tashiro, Manabu; Sakurada, Yumiko; Mochizuki, Hideki; Horikawa, Etsuo; Maruyama, Masahiro; Okamura, Nobuyuki; Watanuki, Shoichi; Arai, Hiroyuki; Itoh, Masatoshi; Yanai, Kazuhiko.

In: Human Psychopharmacology, Vol. 23, No. 2, 01.03.2008, p. 139-150.

Research output: Contribution to journalArticle

Tashiro, M, Sakurada, Y, Mochizuki, H, Horikawa, E, Maruyama, M, Okamura, N, Watanuki, S, Arai, H, Itoh, M & Yanai, K 2008, 'Effects of a sedative antihistamine, D-chlorpheniramine, on regional cerebral perfusion and performance during simulated car driving', Human Psychopharmacology, vol. 23, no. 2, pp. 139-150. https://doi.org/10.1002/hup.909
Tashiro, Manabu ; Sakurada, Yumiko ; Mochizuki, Hideki ; Horikawa, Etsuo ; Maruyama, Masahiro ; Okamura, Nobuyuki ; Watanuki, Shoichi ; Arai, Hiroyuki ; Itoh, Masatoshi ; Yanai, Kazuhiko. / Effects of a sedative antihistamine, D-chlorpheniramine, on regional cerebral perfusion and performance during simulated car driving. In: Human Psychopharmacology. 2008 ; Vol. 23, No. 2. pp. 139-150.
@article{8c697b058f7046a28db06a3c8d96dc77,
title = "Effects of a sedative antihistamine, D-chlorpheniramine, on regional cerebral perfusion and performance during simulated car driving",
abstract = "Objectives: The sedative side effects of antihistamines have been recognized to be potentially dangerous in car driving, but the mechanism underlying these effects has not yet been elucidated to date. The aim of the present study is to examine regional cerebral blood flow (rCBF) responses during a simulated car-driving task following oral administration of D-chlorpheniramine using positron emission tomography (PET) and [15O]H2O, based on a single-blind cross-over study-design. Methods: Right-handed, healthy male volunteers (n = 14) drove a car in a simulated environment following oral administration of D-chlorpheniramine repetab 6 mg or placebo. Their rCBF was measured using PET with [15O]H2O in the following three conditions: (1) resting, (2) active driving, and (3) passive driving. All 'in-car' views during the simulated driving were videotaped and used for rating driving performance. Results: Performance evaluation revealed that the number of lane deviations significantly increased in the D-chlorpheniramine condition compared with the placebo condition (p <0.01). Subjective sleepiness was not significantly different between the two drug conditions. The regions of diminished brain responses following D-chlorpheniramine treatment were detected in the parietal, temporal and visual cortices, and in the cerebellum. The regions of augmented rCBF responses were found in the orbitofrontal cortex and cerebellar vermis. Conclusion: These results suggest that D-chlorpheniramine tends to suppress visuo-spatial cognition and visuo-motor coordinating functions rather than attention and motor functions during car driving.",
keywords = "Antihistamine, Car driving, Cerebral blood flow, Impaired performance, PET",
author = "Manabu Tashiro and Yumiko Sakurada and Hideki Mochizuki and Etsuo Horikawa and Masahiro Maruyama and Nobuyuki Okamura and Shoichi Watanuki and Hiroyuki Arai and Masatoshi Itoh and Kazuhiko Yanai",
year = "2008",
month = "3",
day = "1",
doi = "10.1002/hup.909",
language = "English (US)",
volume = "23",
pages = "139--150",
journal = "Human Psychopharmacology",
issn = "0885-6222",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Effects of a sedative antihistamine, D-chlorpheniramine, on regional cerebral perfusion and performance during simulated car driving

AU - Tashiro, Manabu

AU - Sakurada, Yumiko

AU - Mochizuki, Hideki

AU - Horikawa, Etsuo

AU - Maruyama, Masahiro

AU - Okamura, Nobuyuki

AU - Watanuki, Shoichi

AU - Arai, Hiroyuki

AU - Itoh, Masatoshi

AU - Yanai, Kazuhiko

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Objectives: The sedative side effects of antihistamines have been recognized to be potentially dangerous in car driving, but the mechanism underlying these effects has not yet been elucidated to date. The aim of the present study is to examine regional cerebral blood flow (rCBF) responses during a simulated car-driving task following oral administration of D-chlorpheniramine using positron emission tomography (PET) and [15O]H2O, based on a single-blind cross-over study-design. Methods: Right-handed, healthy male volunteers (n = 14) drove a car in a simulated environment following oral administration of D-chlorpheniramine repetab 6 mg or placebo. Their rCBF was measured using PET with [15O]H2O in the following three conditions: (1) resting, (2) active driving, and (3) passive driving. All 'in-car' views during the simulated driving were videotaped and used for rating driving performance. Results: Performance evaluation revealed that the number of lane deviations significantly increased in the D-chlorpheniramine condition compared with the placebo condition (p <0.01). Subjective sleepiness was not significantly different between the two drug conditions. The regions of diminished brain responses following D-chlorpheniramine treatment were detected in the parietal, temporal and visual cortices, and in the cerebellum. The regions of augmented rCBF responses were found in the orbitofrontal cortex and cerebellar vermis. Conclusion: These results suggest that D-chlorpheniramine tends to suppress visuo-spatial cognition and visuo-motor coordinating functions rather than attention and motor functions during car driving.

AB - Objectives: The sedative side effects of antihistamines have been recognized to be potentially dangerous in car driving, but the mechanism underlying these effects has not yet been elucidated to date. The aim of the present study is to examine regional cerebral blood flow (rCBF) responses during a simulated car-driving task following oral administration of D-chlorpheniramine using positron emission tomography (PET) and [15O]H2O, based on a single-blind cross-over study-design. Methods: Right-handed, healthy male volunteers (n = 14) drove a car in a simulated environment following oral administration of D-chlorpheniramine repetab 6 mg or placebo. Their rCBF was measured using PET with [15O]H2O in the following three conditions: (1) resting, (2) active driving, and (3) passive driving. All 'in-car' views during the simulated driving were videotaped and used for rating driving performance. Results: Performance evaluation revealed that the number of lane deviations significantly increased in the D-chlorpheniramine condition compared with the placebo condition (p <0.01). Subjective sleepiness was not significantly different between the two drug conditions. The regions of diminished brain responses following D-chlorpheniramine treatment were detected in the parietal, temporal and visual cortices, and in the cerebellum. The regions of augmented rCBF responses were found in the orbitofrontal cortex and cerebellar vermis. Conclusion: These results suggest that D-chlorpheniramine tends to suppress visuo-spatial cognition and visuo-motor coordinating functions rather than attention and motor functions during car driving.

KW - Antihistamine

KW - Car driving

KW - Cerebral blood flow

KW - Impaired performance

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=40549123703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40549123703&partnerID=8YFLogxK

U2 - 10.1002/hup.909

DO - 10.1002/hup.909

M3 - Article

C2 - 18181241

AN - SCOPUS:40549123703

VL - 23

SP - 139

EP - 150

JO - Human Psychopharmacology

JF - Human Psychopharmacology

SN - 0885-6222

IS - 2

ER -